Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|September 4, 2012
Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumorsLaura A Petrillo, Denise M Wolf, Ann M Kapoun, et al.
Breast Cancer Research and Treatment|February 15, 2016
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignanciesAmy Jo Chien, Alyson Cockerill, Craig Fancourt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2006
Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' GroupNadine Andrieu, Douglas F Easton, Jenny Chang-Claude, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 28, 2002
Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokersFrederik Jan Van Schooten, Ahmad Besaratinia, Ahmad Besarati Nia, et al.
The Lancet. Oncology|March 3, 2006
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort studySusan M Domchek, Tara M Friebel, Susan L Neuhausen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2018
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)Mark Jesus M Magbanua, Hope S Rugo, Denise M Wolf, et al.
Journal of the National Cancer Institute|September 7, 2006
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancerMarc Buyse, Sherene Loi, Laura van't Veer, et al.
Journal of the American Medical Informatics Association : JAMIA|July 16, 2015
The NIH BD2K center for big data in translational genomicsBenedict Paten, Mark Diekhans, Brian J Druker, et al.
JCO Precision Oncology|September 11, 2020
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIALJulia D Wulfkuhle, Christina Yau, Denise M Wolf, et al.
Breast Cancer Research and Treatment|January 28, 2026
Breast cancer risk level and prediction of tumor aggressiveness in the Athena Breast Health NetworkKatherine Leggat-Barr, Tomiyuri Lewis, Jeffrey A Tice, et al.
Pageof 5